Unshackling Drug Prices From Pharmacy Benefit Managers
Dr. Robert Levin, President of the Alliance for Transparent and Affordable Prescriptions (ATAP) and Florida Society of Rheumatology (FSR) Advocacy Chair – “It’s time for... Continue Reading
Latest News
The ‘great American switching experiment’: Cyltezo debut ushers in interchangeable era
Robert W. Levin, MD – “Patients are going to go to the pharmacy to get an injectable, and suddenly they are presented with a different device or syringe,” he said. “Th... Continue Reading
FSR Advocates Help Lead Charge to Support Florida’s Rheumatology Community
Session in Tallahassee is coming to a close, but FSR's advocates have been busy working to support rheumatology friendly policies. FSR advocates sent 245 letters of support to... Continue Reading
Florida’s Rheumatology Leaders Assemble in Tallahassee to Educate State Legislators
FSR hosted a record number of advocates representing a variety of districts across the state. While there are several legislative issues impacting the rheumatology community, ... Continue Reading
Pharmacy benefit manager reform will increase transparency, access | Commentary
Six in 10 adults report currently taking at least one prescription medication and see their pharmacist twice as often as any other health-care provider. Despite the pivotal ro... Continue Reading
Will Medicare stand in the way of innovative rheumatoid arthritis treatment? | Column
Rheumatoid arthritis is an autoimmune disease that affects millions of Americans, causing pain, stiffness, and swelling in the joints. If left inadequately treated, rheumatoid... Continue Reading
It takes a village: Rheumatology trainees require multiple mentors, commitment
From the latter stages of medical school to the precarious steps involved in carving out a subspecialty, and throughout the turbulent transitions experienced by young physicia... Continue Reading
Copay Accumulator and Maximizer Update: Adoption Plateaus as Insurers Battle Patients Over Copay Support
Is the gold rush in copay accumulators and maximizers slowing down? Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs. Ac... Continue Reading